Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Certainly looking forward to Gumbo's analysis of
the possible licensing strategy that would charge for the cost to litigate minus a 25% discount, say, to entice everyone to sign on the dotted line. Or what the strategy would be going forward with an ITC loss. Will PTSC still make money over the next couple years? As I am, I suspect everyone will be back in the office tomorrow.
Share
New Message
Please login to post a reply